Dyne Therapeutics, Inc. DYN Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s other income, net (note 6)?
- Dyne Therapeutics, Inc. (DYN) reported other income, net (note 6) of $4.42M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s other income, net (note 6) changed year-over-year?
- Dyne Therapeutics, Inc.'s other income, net (note 6) decreased by 36.9% year-over-year, from $7.01M to $4.42M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s other income, net (note 6)?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s other income, net (note 6) has grown at a 133.9% compound annual growth rate (CAGR), from $734K to $21.97M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.